The histamine autoreceptor is a short isoform of the H 3 receptor

British Journal of Pharmacology

Volumn 166, Issue 6, 2012, Pages 1860-1871

  Gbahou, F ^a   Rouleau, A ^a   Arrang, Jean Michel ^a  

^a CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

Author keywords

Autoreceptor; Coupling properties; Enantiomers; Histamine H 3 receptor; Isoforms; Rat brain; Stereoselectivity

Indexed keywords

ALPHA METHYLHISTAMINE; CALCIMYCIN; CYCLIC AMP; FORSKOLIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HISTAMINE H3 RECEPTOR; N METHYLHISTAMINE; SOPROMIDINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BINDING SITE; BRAIN CORTEX; CORPUS STRIATUM; ENANTIOMER; HISTAMINE RELEASE; HYPOTHALAMUS; IC 50; MOLECULAR CLONING; MOLECULAR INTERACTION; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR BLOCKING; RECEPTOR DENSITY; RECEPTOR POTENTIAL; STEREOCHEMISTRY;

ANIMALS; ARACHIDONIC ACID; AUTORECEPTORS; BRAIN; CALCIMYCIN; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; FORSKOLIN; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HISTAMINE; IMIDAZOLES; MALE; METHYLHISTAMINES; PROTEIN ISOFORMS; RATS; RATS, WISTAR; RECEPTORS, HISTAMINE H3;

EID: 84863219372     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.01913.x     Document Type: Article

References (65)

1. Alexander SPH, Mathie A, Peters JA (2011). Guide to Receptors and Channels (GRAC), 5th edn. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. 3 receptors in the brain of 6-hydroxydopamine-lesioned rats. Eur J Neurosci 12: 3823-3832.
3. 3 receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease. Neurobiol Dis 8: 707-716.
4. Arrang JM, Garbarg M, Schwartz JC (1983). Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302: 832-837. (Pubitemid 13125123)
5. 3-presynaptic autoreceptor. Eur J Pharmacol 117: 109-114.
6. Arrang JM, Garbarg M, Quach TT, Dam Trung Tuong M, Yeramian E, Schwartz JC (1985b). Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol 111: 73-84. (Pubitemid 15097843)
7. Arrang JM, Garbarg M, Lancelot JC, Lecomte JM, Pollard H, Robba M et al. (1987). Highly potent and selective ligands for histamine H3-receptors. Nature 327: 117-123. (Pubitemid 17062756)
8. 3 receptor binding sites in rat brain membranes: modulations by guanine nucleotides and divalent cations. Eur J Pharmacol 188: 219-227.
9. 3 receptor. Trends Pharmacol Sci 28: 350-357.
10. 3isoform confers pharmacological differences and constitutive activity. J Pharmacol Exp Ther 323: 888-898.
11. 3-receptor inverse agonists. Psychopharmacology (Berl) 210: 591-604.
12. 3 receptor antagonists reach out for the clinic. Drug Discov Today 10: 1613-1627.
13. 2 L receptors. Neuropsychopharmacology 27: 723-726.
14. i) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108.
15. Coge F, Guenin SP, Audinot V, Renouard-Try A, Beauverger P, Macia C et al. (2001). Genomic organization and characterization of splice variants of the human histamine H3 receptor. Biochem J 355: 279-288. (Pubitemid 32397785)
16. 3 receptor: characterization and autoradiographic localization in rat brain. Synapse 8: 144-151.
17. 3 receptor isoforms with different brain expression and signaling properties. Mol Pharmacol 59: 1-8.
18. 3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders. Mol Interv 6: 77-88, 59.
19. 3 receptors in vitro and in vivo. Proc Natl Acad Sci U S A 100: 11086-11091.
20. 4 receptors: structure-activity relationships of histamine derivatives. Br J Pharmacol 147: 744-754.
21. 3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo. J Pharmacol Exp Ther 334: 945-954.
22. 3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases. Eur J Neurosci 11: 449-456.
23. 2 receptor directs specificity of coupling to G-proteins. J Biol Chem 270: 7354-7358.
24. Haas HL, Sergeeva OA, Selbach O (2008). Histamine in the nervous system. Physiol Rev 88: 1183-1241.
25. 3 receptor antagonists/inverse agonists as anti-obesity agents. Curr Opin Investig Drugs 4: 1190-1197.
26. 3receptor ligands and neurological disease. Expert Opin Investig Drugs 13: 1237-1248.
27. 3 receptor heterogeneity. Life Sci 73: 3043-3072.
28. 2 receptor isoforms in cultured neurons reveals equipotent autoreceptor function. Neuropharmacology 50: 595-605.
29. Kamei C (2001). Involvement of central histamine in amygdaloid kindled seizures in rats. Behav Brain Res 124: 243-250.
30. 2 short isoform in dopaminergic pathways. Proc Natl Acad Sci U S A 95: 7731-7736.
31. 3 receptor. J Labelled Comp Radiopharm 39: 601-606.
32. 3 receptor drugs. Nat Rev Drug Discov 4: 107-120.
33. 3 receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. Neurobiol Dis 30: 74-83.
34. 2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc Natl Acad Sci U S A 100: 4305-4309.
35. 3 dopamine receptors stably transfected into NG108-15 cells couple to a voltage-dependent potassium current via distinct G protein mechanisms. Synapse 24: 156-164.
36. Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A et al. (1999). Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 55: 1101-1107. (Pubitemid 29252378)
37. 3 receptors in pig brain by quantitative autoradiography. Eur J Pharmacol 564: 75-79.
38. 3 receptor regulation of histamine synthesis and release. Neuroscience 164: 1244-1251.
39. 3receptors regulates histamine neurons in brain. Nature 408: 860-864.
40. 3 receptor: gene organization and multiple isoforms. Biochem Biophys Res Commun 280: 75-80.
41. 3-receptor antagonist/inverse agonist, modulates methamphetamine- induced sensitization in mice. Eur J Neurosci 33: 1197-1204.
42. Panula P, Airaksinen M (1991). The histaminergic neuronal system as revealed with antisera against histamine. In: Watanabe T, Wada H (eds). Histaminergic Neurons: Morphology and Function. CRC: Boca Raton, FL, pp. 127-144.
43. 3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders. Biochem Pharmacol 73: 1157-1171.
44. 3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol Sci 25: 618-625.
45. 3receptor and its gene transcripts in rat brain. Neuroscience 114: 173-193.
46. 3 receptors in rat brain areas. Neuroscience 52: 169-189.
47. 3 receptors. Br J Pharmacol 135: 383-392.
48. 3receptor: evidence for multiple isoforms. J Neurochem 90: 1331-1338.
49. 3heteroreceptors. Fundam Clin Pharmacol 8: 128-137.
50. 2 dopamine receptor isoforms signal through distinct Gi alpha proteins to inhibit adenylyl cyclase. A study with site-directed mutant Gi alpha proteins. J Biol Chem 269: 23120-23127.
51. 3 receptor antagonist GSK207040. Psychopharmacology (Berl) 201: 483-494.
52. Stevens DR, Eriksson KS, Brown RE, Haas HL (2001). The mechanism of spontaneous firing in histamine neurons. Behav Brain Res 124: 105-112. (Pubitemid 32964627)
53. 3 receptor isoforms. Eur J Pharmacol 601: 8-15.
54. Takeshita Y, Watanabe T, Sakata T, Munakata M, Ishibashi H, Akaike N (1998). Histamine modulates high-voltage-activated calcium channels in neurons dissociated from the rat tuberomammillary nucleus. Neuroscience 87: 797-805. (Pubitemid 28400350)
55. 3 receptor: evidence for two isoforms. Neuroreport 11: 755-759.
56. Tardivel-Lacombe J, Morisset S, Gbahou F, Schwartz JC, Arrang JM (2001). Chromosomal mapping and organization of the human histamine H3 receptor gene. Neuroreport 12: 321-324. (Pubitemid 32114373)
57. Tohyama M, Tamiya R, Inagaki N, Takagi H (1991). Morphology of histaminergic neurons with histidine decarboxylase as a marker. In: Watanabe T, Wada H (eds). Histaminergic Neurons: Morphology and Function. CRC: Boca Raton, FL, pp. 107-126.
58. 2receptors. Nature 408: 199-203.
59. 2L receptors to inhibit ERK1/2 phosphorylation. J Neurochem 102: 1796-1804.
60. Wellendorph P, Goodman MW, Burstein ES, Nash NR, Brann MR, Weiner DM (2002). Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H3 receptor. Neuropharmacology 42: 929-940. (Pubitemid 34632680)
61. 3receptor inverse agonist radioligand. Br J Pharmacol 148: 657-670.
62. 2 receptor isoforms expressed in AtT20 cells differentially couple to G proteins to acutely inhibit high voltage-activated calcium channels. J Neurochem 73: 2375-2382.
63. Wouterlood F, Steinbusch H (1991). Afferent and efferent fiber connections of histaminergic neurons in the rat brain: comparison with dopaminergic, noradrenergic and serotonergic systems. In: Watanabe T, Wada H (eds). Histaminergic Neurons: Morphology and Function. CRC: Boca Raton, FL, pp. 145-162.
64. Wulff BS, Hastrup S, Rimvall K (2002). Characteristics of recombinantly expressed rat and human histamine H3 receptors. Eur J Pharmacol 453: 33-41. (Pubitemid 35232452)
65. 3 receptor. Neuropharmacology 50: 468-478.